Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Total 13F shares
-
59,255,636
-
Share change
-
+15,668,509
-
Total reported value
-
$2,326,748,242
-
Put/Call ratio
-
36%
-
Price per share
-
$39.27
-
Number of holders
-
164
-
Value change
-
+$609,713,327
-
Number of buys
-
121
-
Number of sells
-
45
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q2 2024
As of 30 Jun 2024,
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,255,636 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, JANUS HENDERSON GROUP PLC, Capital Research Global Investors, Driehaus Capital Management LLC, BVF INC/IL, FEDERATED HERMES, INC., PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., and Capital International Investors.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.